跳到主要导航
跳到搜索
跳到主要内容
Pure University (For Demo Only) 国内
帮助和常见问题
English
中文
国内
简介
研究单位
科研成果
设备
数据集
活动
奖项
影响
项目
新闻 / 媒体
按专业知识、名称或附属进行搜索
联系专家
查看 Scopus 资料
Laprairie Robert B.
Associate Professor
Dalhousie University
,
Medicine
电子邮件
LR980400
dal
ca
网站
https://www.scopus.com/authid/detail.url?authorId=55316980400
h-index
h10-index
h5-index
2912
引用
24
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
2576
引用
21
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
545
引用
12
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
2012
2023
每年的科研成果
综述
指纹
网络
科研成果
(69)
新闻 / 媒体
(33)
相似简介
(6)
指纹
深入其中 Laprairie Robert B. 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Neuroscience
Cannabinoid
100%
Cannabinoid Receptor Type 1
55%
Eicosanoid Receptor
54%
Cannabinoid Receptor
49%
Behavior (Neuroscience)
43%
Endocannabinoid
41%
Orexin
35%
Cell Culture
33%
Huntington's Disease
32%
Spike-and-Wave
29%
Tetrahydrocannabinol
26%
Agonist
26%
Cannabidiol
24%
Cannabis
23%
Orexin Receptor
23%
Receptor Expression
21%
Receptor Agonists
19%
Huntingtin
18%
Cell Signaling
18%
Positive Allosteric Modulator
18%
Cannabinoid 1 Receptor
18%
Diethylstilbestrol
18%
Functional Selectivity
17%
Promoter Region
16%
Opiate
16%
Physical Dependence
16%
Somatics
16%
Pharmacokinetics
15%
Amino Terminal Sequence
15%
Dual Orexin Receptor Antagonist
15%
Posttraumatic Stress Disorder
14%
Antipsychotic
14%
Psilocybin
14%
Lysergic Acid Diethylamide
14%
Psilocin
14%
Automutilation
14%
Coding Region
14%
Lipidome
14%
Epileptic Absence
14%
Uveitis
14%
Cannabinoid Receptor Type 2
14%
Irreversible Antagonist
14%
Morphine
14%
Rimonabant
14%
Catalepsy
13%
Endocannabinoid System
9%
G Protein Coupled Receptor
9%
Sex Hormone
8%
Childhood Absence Epilepsy
8%
Lipid Raft
8%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabinoid 1 Receptor
89%
Cannabinoid
77%
Allosteric Modulator
48%
Cannabis
44%
Receptor
44%
Tetrahydrocannabinol
38%
Positive Allosteric Modulator
33%
Cell Culture
32%
Endocannabinoid System
30%
Cannabidiol
29%
Huntington Chorea
29%
Mouse Model
29%
Cannabinoid Receptor
22%
Disease
20%
Long Evans Rat
18%
Drug Dependence
17%
Endocannabinoid
16%
Cannabis Sativa
16%
Functional Selectivity
16%
Transgenic Mouse
15%
Pharmacological Activity
14%
Lysergide
14%
Psilocin
14%
Dopamine Receptor D2
14%
Endotoxin-Induced Uveitis
14%
Lipidome
14%
Physical Disease by Body Function
14%
Orexin
14%
4 (1,1 Dimethylheptyl) 1',2',3',4',5',6' Hexahydro 2,3' Dihydroxy 6' (3 Hydroxypropyl)biphenyl
14%
Cytokine
14%
Psychotomimetic
14%
Serotonin 2A Receptor
14%
Posttraumatic Stress Disorder
14%
Epileptic Absence
14%
Automutilation
14%
Carisoprodol
14%
Nervous System Inflammation
12%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
11%
Acute Psychosis
9%
Phenylalkylamine
9%
Phenethylamine
9%
Mouse
9%
Green Fluorescent Protein
8%
Phosphotransferase
8%
Retina S Antigen
8%
G Protein Coupled Receptor
7%
Target Activity
7%
Orexin Receptor
7%
Dopamine Receptor
5%
Receptor Subtype
5%
Keyphrases
Cannabinoid Receptor 1 (CB1R)
75%
CB1 Receptor
35%
Striatal
29%
Cell Culture Model
29%
Medium Spiny Neurons
29%
Cannabidiol
26%
Cannabinoids
26%
Δ9-tetrahydrocannabinol (Δ9-THC)
23%
Negative Allosteric Modulator
20%
Transcriptional Dysregulation
16%
Cannabis Sativa
16%
Antagonism
16%
2-Arachidonoylglycerol (2-AG)
15%
Publicly Available
14%
Microarray Data
14%
Dopamine System
14%
Neuroblastoma Cancer
14%
2-oxopyridines
14%
In Vitro Characterization
14%
Nanomaterials
14%
Bias Characterization
14%
Endocannabinoid Receptors
14%
Minor Cannabinoids
14%
CB 1
14%
Gpcr
14%
Pharmacological Activities
14%
Psilocin
14%
Signaling Profile
14%
Lysergic Acid Diethylamide
14%
Fabp
14%
FABP7
14%
Zebrafish
14%
Phytomolecules
14%
Design Activity
14%
Enantiospecificity
14%
Dopamine D2 Receptor (DRD2)
14%
Neuronal Viability
14%
Covalent Probes
14%
Allosteric Site
14%
Electrophilic
14%
5-choice Serial Reaction Time Task
14%
Photoaffinity
14%
Allosteric Interactions
14%
Immune Cell Activity
14%
Agonist Selectivity
14%
Synthetic Cannabinoid Receptor Agonists
14%
CB 2
14%
Agonist Bias
14%
Preclinical Efficacy
14%
Pharmacological Profile
14%
